Why ACRS? Aclaris Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
ACRS
$4.83+0.09 (+1.79%)
Market OpenUpdated 10:34 AM EDT
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.